Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • M.D., New York University 1983
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Jackson, Timothy L., Jason Slakter, Marc Buyse, Kun Wang, Pravin U. Dugel, Charles C. Wykoff, David S. Boyer, et al. “A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration.” Ophthalmology 130, no. 6 (June 2023): 588–97. https://doi.org/10.1016/j.ophtha.2023.02.001.
       Full Text  Link to Item
    • Freeman, William R., Francesco Bandello, Eric Souied, Robyn H. Guymer, Sunir J. Garg, Fred K. Chen, Ryan Rich, et al. “Randomized Phase IIb Study of Brimonidine Drug Delivery System Generation 2 for Geographic Atrophy in Age-Related Macular Degeneration.” Ophthalmol Retina, March 10, 2023. https://doi.org/10.1016/j.oret.2023.03.001.
       Full Text  Link to Item
    • Marcus, Dennis M., Paolo S. Silva, Danni Liu, Lloyd Paul Aiello, Andrew Antoszyk, Michael Elman, Scott Friedman, et al. “Association of Predominantly Peripheral Lesions on Ultra-Widefield Imaging and the Risk of Diabetic Retinopathy Worsening Over Time.” Jama Ophthalmol 140, no. 10 (October 1, 2022): 946–54. https://doi.org/10.1001/jamaophthalmol.2022.3131.
       Full Text  Link to Item
    • Silva, Paolo S., Dennis M. Marcus, Danni Liu, Lloyd Paul Aiello, Andrew Antoszyk, Michael Elman, Scott Friedman, et al. “Association of Ultra-Widefield Fluorescein Angiography-Identified Retinal Nonperfusion and the Risk of Diabetic Retinopathy Worsening Over Time.” Jama Ophthalmol 140, no. 10 (October 1, 2022): 936–45. https://doi.org/10.1001/jamaophthalmol.2022.3130.
       Full Text  Link to Item
    • Heier, Jeffrey S., Arshad M. Khanani, Carlos Quezada Ruiz, Karen Basu, Philip J. Ferrone, Christopher Brittain, Marta S. Figueroa, et al. “Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.” Lancet 399, no. 10326 (February 19, 2022): 729–40. https://doi.org/10.1016/S0140-6736(22)00010-1.
       Full Text  Link to Item
    • Wykoff, Charles C., Francis Abreu, Anthony P. Adamis, Karen Basu, David A. Eichenbaum, Zdenka Haskova, Hugh Lin, et al. “Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.” Lancet 399, no. 10326 (February 19, 2022): 741–55. https://doi.org/10.1016/S0140-6736(22)00018-6.
       Full Text  Link to Item
    • Glassman, Adam R., Wesley T. Beaulieu, Maureen G. Maguire, Andrew N. Antoszyk, Clement C. Chow, Michael J. Elman, Lee M. Jampol, Hani Salehi-Had, Jennifer K. Sun, and Jennifer K. DRCR Retina Network. “Visual Acuity, Vitreous Hemorrhage, and Other Ocular Outcomes After Vitrectomy vs Aflibercept for Vitreous Hemorrhage Due to Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial.” Jama Ophthalmol 139, no. 7 (July 1, 2021): 725–33. https://doi.org/10.1001/jamaophthalmol.2021.1110.
       Full Text  Link to Item
    • Maturi, Raj K., Adam R. Glassman, Kristin Josic, Andrew N. Antoszyk, Barbara A. Blodi, Lee M. Jampol, Dennis M. Marcus, et al. “Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial.” Jama Ophthalmol 139, no. 7 (July 1, 2021): 701–12. https://doi.org/10.1001/jamaophthalmol.2021.0606.
       Full Text  Link to Item
    • Antoszyk, Andrew N., Adam R. Glassman, Wesley T. Beaulieu, Lee M. Jampol, Chirag D. Jhaveri, Omar S. Punjabi, Hani Salehi-Had, et al. “Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.” Jama 324, no. 23 (December 15, 2020): 2383–95. https://doi.org/10.1001/jama.2020.23027.
       Full Text  Link to Item
    • Antoszyk, Andrew N., Kathleen Wade Tarnowski, Karen Basu, Jason S. Ehrlich, and Zdenka Haskova. “Ranibizumab in Diabetic Retinopathy with or without Diabetic Macular Edema.” Ophthalmol Retina 4, no. 10 (October 2020): 1034–36. https://doi.org/10.1016/j.oret.2020.05.020.
       Full Text  Link to Item
    • Glassman, Adam R., John A. Wells, Kristin Josic, Maureen G. Maguire, Andrew N. Antoszyk, Carl Baker, Wesley T. Beaulieu, Michael J. Elman, Lee M. Jampol, and Jennifer K. Sun. “Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study).” Ophthalmology 127, no. 9 (September 2020): 1201–10. https://doi.org/10.1016/j.ophtha.2020.03.021.
       Full Text  Link to Item
    • Dugel, Pravin U., David S. Boyer, Andrew N. Antoszyk, Nathan C. Steinle, Michael P. Varenhorst, Joel A. Pearlman, Mark C. Gillies, Robert P. Finger, Megan E. Baldwin, and Ian M. Leitch. “Phase 1 Study of OPT-302 Inhibition of Vascular Endothelial Growth Factors C and D for Neovascular Age-Related Macular Degeneration.” Ophthalmol Retina 4, no. 3 (March 2020): 250–63. https://doi.org/10.1016/j.oret.2019.10.008.
       Full Text  Link to Item
    • Keenan, Tiarnan D., Susan Vitale, Elvira Agrón, Amitha Domalpally, Andrew N. Antoszyk, Michael J. Elman, Traci E. Clemons, Emily Y. Chew, and Emily Y. Age-Related Eye Disease Study 2 Research Group. “Visual Acuity Outcomes after Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 19.” Ophthalmol Retina 4, no. 1 (January 2020): 3–12. https://doi.org/10.1016/j.oret.2019.06.001.
       Full Text  Link to Item
    • Punjabi, Omar S., David J. Browning, Loraine Clark, and Andrew N. Antoszyk. “"Pacman" invasion of the retina: Two cases of ophthalmomyiasis interna posterior.” Am J Ophthalmol Case Rep 15 (September 2019): 100491. https://doi.org/10.1016/j.ajoc.2019.100491.
       Full Text  Link to Item
    • Baker, Carl W., Adam R. Glassman, Wesley T. Beaulieu, Andrew N. Antoszyk, David J. Browning, Kakarla V. Chalam, Sandeep Grover, et al. “Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial.” Jama 321, no. 19 (May 21, 2019): 1880–94. https://doi.org/10.1001/jama.2019.5790.
       Full Text  Link to Item
    • Yu, Jeannette J., Elvira Agrón, Traci E. Clemons, Amitha Domalpally, Freekje van Asten, Tiarnan D. Keenan, Catherine Cukras, Emily Y. Chew, and Emily Y. Age-Related Eye Disease Study 2 Research Group. “Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17.” Ophthalmology 126, no. 2 (February 2019): 261–73. https://doi.org/10.1016/j.ophtha.2018.08.017.
       Full Text  Link to Item
    • Aiello, Lloyd Paul, Isoken Odia, Adam R. Glassman, Michele Melia, Lee M. Jampol, Neil M. Bressler, Szilard Kiss, et al. “Comparison of Early Treatment Diabetic Retinopathy Study Standard 7-Field Imaging With Ultrawide-Field Imaging for Determining Severity of Diabetic Retinopathy.” Jama Ophthalmol 137, no. 1 (January 1, 2019): 65–73. https://doi.org/10.1001/jamaophthalmol.2018.4982.
       Full Text  Link to Item
    • Keenan, Tiarnan D., Elvira Agrón, Amitha Domalpally, Traci E. Clemons, Freekje van Asten, Wai T. Wong, Ronald G. Danis, et al. “Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16.” Ophthalmology 125, no. 12 (December 2018): 1913–28. https://doi.org/10.1016/j.ophtha.2018.05.028.
       Full Text  Link to Item
    • Gross, Jeffrey G., Adam R. Glassman, Danni Liu, Jennifer K. Sun, Andrew N. Antoszyk, Carl W. Baker, Neil M. Bressler, et al. “Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.” Jama Ophthalmol 136, no. 10 (October 1, 2018): 1138–48. https://doi.org/10.1001/jamaophthalmol.2018.3255.
       Full Text  Link to Item
    • Jampol, Lee M., Adam R. Glassman, Danni Liu, Lloyd Paul Aiello, Neil M. Bressler, Elia J. Duh, Susan Quaggin, John A. Wells, Charles C. Wykoff, and Charles C. Diabetic Retinopathy Clinical Research Network. “Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema.” Ophthalmology 125, no. 7 (July 2018): 1054–63. https://doi.org/10.1016/j.ophtha.2018.01.019.
       Full Text  Link to Item
    • Birch, David G., Matthew S. Benz, Daniel M. Miller, Andrew N. Antoszyk, Joseph Markoff, Petra Kozma, Esmeralda Meunier, Robert C. Sergott, and Robert C. OASIS Study Team. “EVALUATION OF FULL-FIELD ELECTRORETINOGRAM REDUCTIONS AFTER OCRIPLASMIN TREATMENT: Results of the OASIS Trial ERG Substudy.” Retina 38, no. 2 (February 2018): 364–78. https://doi.org/10.1097/IAE.0000000000001536.
       Full Text  Link to Item
    • Birch, David G., Matthew S. Benz, Daniel M. Miller, Andrew N. Antoszyk, Joseph Markoff, Petra Kozma, Esmeralda Meunier, and Robert C. Sergott. “EVALUATION OF FULL-FIELD ELECTRORETINOGRAM REDUCTIONS AFTER OCRIPLASMIN TREATMENT Results of the OASIS Trial ERG Substudy.” Retina the Journal of Retinal and Vitreous Diseases 38, no. 2 (February 1, 2018): 364–78.
       Link to Item
    • Antoszyk, Andrew N., Carl Baker, Jorge Calzada, Howard Cummings, Joanna So, Carlos Quezada-Ruiz, and Zdenka Haskova. “Usability of the Ranibizumab 0.5 mg Prefilled Syringe: Human Factors Studies to Evaluate Critical Task Completion by Healthcare Professionals.” Pda J Pharm Sci Technol 72, no. 4 (2018): 411–19. https://doi.org/10.5731/pdajpst.2017.008342.
       Full Text  Link to Item
    • Maturi, Raj K., Adam R. Glassman, Danni Liu, Roy W. Beck, Abdhish R. Bhavsar, Neil M. Bressler, Lee M. Jampol, et al. “Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical Trial.” Jama Ophthalmol 136, no. 1 (January 1, 2018): 29–38. https://doi.org/10.1001/jamaophthalmol.2017.4914.
       Full Text  Link to Item
    • Scott, Ingrid U., Paul C. VanVeldhuisen, Michael S. Ip, Barbara A. Blodi, Neal L. Oden, Jacqueline King, Andrew N. Antoszyk, Mark A. Peters, Michael Tolentino, and Michael SCORE2 Investigator Group. “Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4.” Jama Ophthalmol 135, no. 6 (June 1, 2017): 639–49. https://doi.org/10.1001/jamaophthalmol.2017.1141.
       Full Text  Link to Item
    • Wells, John A., Adam R. Glassman, Lee M. Jampol, Lloyd Paul Aiello, Andrew N. Antoszyk, Carl W. Baker, Neil M. Bressler, et al. “Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema.” Jama Ophthalmol 134, no. 2 (February 2016): 127–34. https://doi.org/10.1001/jamaophthalmol.2015.4599.
       Full Text  Link to Item
    • Writing Committee for the Diabetic Retinopathy Clinical Research Network, Roy W., Jeffrey G. Gross, Adam R. Glassman, Lee M. Jampol, Seidu Inusah, Lloyd Paul Aiello, Andrew N. Antoszyk, et al. “Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.” Jama 314, no. 20 (November 24, 2015): 2137–46. https://doi.org/10.1001/jama.2015.15217.
       Full Text  Link to Item
    • Augustin, Albert J., Baruch D. Kuppermann, Paolo Lanzetta, Anat Loewenstein, Xiao-Yan Li, Harry Cui, Yehia Hashad, Scott M. Whitcup, and Scott M. Ozurdex MEAD Study Group. “Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study.” Bmc Ophthalmol 15 (October 30, 2015): 150. https://doi.org/10.1186/s12886-015-0148-2.
       Full Text  Link to Item
    • Willoughby, Alex S., Gui-Shuang Ying, Cynthia A. Toth, Maureen G. Maguire, Russell E. Burns, Juan E. Grunwald, Ebenezer Daniel, Glenn J. Jaffe, and Glenn J. Comparison of Age-Related Macular Degeneration Treatments Trials Research Group. “Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials.” Ophthalmology 122, no. 9 (September 2015): 1846-53.e5. https://doi.org/10.1016/j.ophtha.2015.05.042.
       Full Text  Link to Item
    • Willoughby, Alex S., Gui-Shuang Ying, Cynthia A. Toth, Maureen G. Maguire, Russell E. Burns, Juan E. Grunwald, Ebenezer Daniel, Glenn J. Jaffe, and Glenn J. Comparison of Age-Related Macular Degeneration Treatments Trials Research Group. “Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials.” Ophthalmology 122, no. 9 (September 2015): 1846-53.e5. https://doi.org/10.1016/j.ophtha.2015.05.042.
       Full Text  Link to Item
    • Aiello, Lloyd Paul, Allison R. Ayala, Andrew N. Antoszyk, Bambi Arnold-Bush, Carl Baker, Neil M. Bressler, Michael J. Elman, et al. “Assessing the Effect of Personalized Diabetes Risk Assessments During Ophthalmologic Visits on Glycemic Control: A Randomized Clinical Trial.” Jama Ophthalmol 133, no. 8 (August 2015): 888–96. https://doi.org/10.1001/jamaophthalmol.2015.1312.
       Full Text  Link to Item
    • Diabetic Retinopathy Clinical Research Network, Roy W., John A. Wells, Adam R. Glassman, Allison R. Ayala, Lee M. Jampol, Lloyd Paul Aiello, Andrew N. Antoszyk, et al. “Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.” N Engl J Med 372, no. 13 (March 26, 2015): 1193–1203. https://doi.org/10.1056/NEJMoa1414264.
       Full Text  Link to Item
    • Diabetic Retinopathy Clinical Research Network, Roy W., John A. Wells, Adam R. Glassman, Allison R. Ayala, Lee M. Jampol, Lloyd Paul Aiello, Andrew N. Antoszyk, et al. “Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.” N Engl J Med 372, no. 13 (March 26, 2015): 1193–1203. https://doi.org/10.1056/NEJMoa1414264.
       Full Text  Link to Item
    • Age-Related Eye Disease Study 2 (AREDS2) Research Group, Robert D., Emily Y. Chew, Traci E. Clemons, John Paul Sangiovanni, Ronald P. Danis, Frederick L. Ferris, Michael J. Elman, et al. “Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.” Jama Ophthalmol 132, no. 2 (February 2014): 142–49. https://doi.org/10.1001/jamaophthalmol.2013.7376.
       Full Text  Link to Item
    • Hutchens, Thomas C., Arash Darafsheh, Amir Fardad, Andrew N. Antoszyk, Howard S. Ying, Vasily N. Astratov, and Nathaniel M. Fried. “Detachable microsphere scalpel tips for potential use in ophthalmic surgery with the erbium:YAG laser.” J Biomed Opt 19, no. 1 (January 2014): 18003. https://doi.org/10.1117/1.JBO.19.1.018003.
       Full Text  Link to Item
    • Age-Related Eye Disease Study 2 (AREDS2) Research Group, Paul, Emily Y. Chew, John Paul SanGiovanni, Frederick L. Ferris, Wai T. Wong, Elvira Agron, Traci E. Clemons, et al. “Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4.” Jama Ophthalmol 131, no. 7 (July 2013): 843–50. https://doi.org/10.1001/jamaophthalmol.2013.4412.
       Full Text  Link to Item
    • Age-Related Eye Disease Study 2 (AREDS2) Research Group, Paul, Emily Y. Chew, John Paul SanGiovanni, Frederick L. Ferris, Wai T. Wong, Elvira Agron, Traci E. Clemons, et al. “Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4.” Jama Ophthalmol 131, no. 7 (July 2013): 843–50. https://doi.org/10.1001/jamaophthalmol.2013.4412.
       Full Text  Link to Item
    • Age-Related Eye Disease Study 2 Research Group, G. “Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.” Jama 309, no. 19 (May 15, 2013): 2005–15. https://doi.org/10.1001/jama.2013.4997.
       Full Text  Link to Item
    • Hutchens, Thomas C., Arash Darafsheh, Amir Fardad, Andrew N. Antoszyk, Howard S. Ying, Vasily N. Astratov, and Nathaniel M. Fried. “Characterization of novel microsphere chain fiber optic tips for potential use in ophthalmic laser surgery.” J Biomed Opt 17, no. 6 (June 2012): 068004. https://doi.org/10.1117/1.JBO.17.6.068004.
       Full Text  Link to Item
    • Diabetic Retinopathy Clinical Research Network, D. K., N. M. Bressler, K. M. Miller, R. W. Beck, S. B. Bressler, A. R. Glassman, J. W. Kitchens, M. Melia, and D. K. Schlossman. “Observational study of subclinical diabetic macular edema.” Eye (Lond) 26, no. 6 (June 2012): 833–40. https://doi.org/10.1038/eye.2012.53.
       Full Text  Link to Item
    • Diabetic Retinopathy Clinical Research Network, D. K., N. M. Bressler, K. M. Miller, R. W. Beck, S. B. Bressler, A. R. Glassman, J. W. Kitchens, M. Melia, and D. K. Schlossman. “Observational study of subclinical diabetic macular edema.” Eye (Lond) 26, no. 6 (June 2012): 833–40. https://doi.org/10.1038/eye.2012.53.
       Full Text  Link to Item
    • Elman, M. J., M. D. Sloan, J. A. Starr, T. M. Butcher, P. V. Singletary, N. Gore, T. Coffey, et al. “Erratum: Observational study of subclinical diabetic macular edema (Eye (2012) 26, (833-840) DOI:10.1038/eye.2012.53).” Eye (Basingstoke) 26, no. 6 (June 1, 2012): 900–901. https://doi.org/10.1038/eye.2012.83.
       Full Text
    • Elman, M. J., M. D. Sloan, J. A. Starr, T. M. Butcher, P. V. Singletary, N. Gore, T. Coffey, et al. “Erratum: Observational study of subclinical diabetic macular edema (Eye (2012) 26, (833-840) DOI:10.1038/eye.2012.53).” Eye (Basingstoke) 26, no. 6 (June 1, 2012): 900–901. https://doi.org/10.1038/eye.2012.83.
       Full Text
    • Singer, Michael A., Carl C. Awh, SriniVas Sadda, William R. Freeman, Andrew N. Antoszyk, Pamela Wong, and Lisa Tuomi. “HORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration.” Ophthalmology 119, no. 6 (June 2012): 1175–83. https://doi.org/10.1016/j.ophtha.2011.12.016.
       Full Text  Link to Item
    • Diabetic Retinopathy Clinical Research Network, Cynthia R., Joseph Googe, Alexander J. Brucker, Neil M. Bressler, Haijing Qin, Lloyd P. Aiello, Andrew Antoszyk, et al. “Randomized trial evaluating short-term effects of intravitreal ranibizumab or triamcinolone acetonide on macular edema after focal/grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation.” Retina 31, no. 6 (June 2011): 1009–27. https://doi.org/10.1097/IAE.0b013e318217d739.
       Full Text  Link to Item
    • Darafsheh, Arash, Amir Fardad, Nathaniel M. Fried, Andrew N. Antoszyk, Howard S. Ying, and Vasily N. Astratov. “Contact focusing multimodal microprobes for ultraprecise laser tissue surgery.” Opt Express 19, no. 4 (February 14, 2011): 3440–48. https://doi.org/10.1364/OE.19.003440.
       Full Text  Link to Item
    • Scott, Ingrid U., Neal L. Oden, Paul C. VanVeldhuisen, Michael S. Ip, Barbara A. Blodi, Andrew N. Antoszyk, and Andrew N. SCORE Study Investigator Group. “SCORE Study Report 7: incidence of intravitreal silicone oil droplets associated with staked-on vs luer cone syringe design.” Am J Ophthalmol 148, no. 5 (November 2009): 725-732.e7. https://doi.org/10.1016/j.ajo.2009.06.004.
       Full Text  Link to Item
    • Ip, Michael S., Neal L. Oden, Ingrid U. Scott, Paul C. VanVeldhuisen, Barbara A. Blodi, Maria Figueroa, Andrew Antoszyk, Michael Elman, and Michael SCORE Study Investigator Group. “SCORE Study report 3: study design and baseline characteristics.” Ophthalmology 116, no. 9 (September 2009): 1770-1777.e1. https://doi.org/10.1016/j.ophtha.2009.03.022.
       Full Text  Link to Item
    • Ying, Gui-shuang, Maureen G. Maguire, Judith Alexander, Revell W. Martin, Andrew N. Antoszyk, and Andrew N. Complications of Age-related Macular Degeneration Prevention Trial  Research Group. “Description of the Age-Related Eye Disease Study 9-step severity scale applied to participants in the Complications of Age-related Macular Degeneration Prevention Trial.” Arch Ophthalmol 127, no. 9 (September 2009): 1147–51. https://doi.org/10.1001/archophthalmol.2009.189.
       Full Text  Link to Item
    • Cordell, William H., Raj K. Maturi, Timothy M. Costigan, Michael F. Marmor, Richard G. Weleber, Stuart G. Coupland, Ronald P. Danis, et al. “Retinal effects of 6 months of daily use of tadalafil or sildenafil.” Arch Ophthalmol 127, no. 4 (April 2009): 367–73. https://doi.org/10.1001/archophthalmol.2009.36.
       Full Text  Link to Item
    • Diabetic Retinopathy Clinical Research Network, John A., Alexander J. Brucker, Haijing Qin, Andrew N. Antoszyk, Roy W. Beck, Neil M. Bressler, David J. Browning, et al. “Observational study of the development of diabetic macular edema following panretinal (scatter) photocoagulation given in 1 or 4 sittings.” Arch Ophthalmol 127, no. 2 (February 2009): 132–40. https://doi.org/10.1001/archophthalmol.2008.565.
       Full Text  Link to Item
    • Ying, Gui-Shuang, Maureen G. Maguire, Chengcheng Liu, Andrew N. Antoszyk, and Andrew N. Complications of Age-related Macular Degeneration Prevention Trial Research Group. “Night vision symptoms and progression of age-related macular degeneration in the Complications of Age-related Macular Degeneration Prevention Trial.” Ophthalmology 115, no. 11 (November 2008): 1876–82. https://doi.org/10.1016/j.ophtha.2008.05.023.
       Full Text  Link to Item
    • Antoszyk, Andrew N., Lisa Tuomi, Carol Y. Chung, Angele Singh, and Angele FOCUS Study Group. “Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration (FOCUS): year 2 results.” Am J Ophthalmol 145, no. 5 (May 2008): 862–74. https://doi.org/10.1016/j.ajo.2007.12.029.
       Full Text  Link to Item
    • Bressler, Neil M., Allison R. Edwards, Andrew N. Antoszyk, Roy W. Beck, David J. Browning, Antonio P. Ciardella, Ronald P. Danis, et al. “Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy.” Am J Ophthalmol 145, no. 5 (May 2008): 894–901. https://doi.org/10.1016/j.ajo.2007.12.025.
       Full Text  Link to Item
    • Ip, Michael S., Susan B. Bressler, Andrew N. Antoszyk, Christina J. Flaxel, Judy E. Kim, Scott M. Friedman, Haijing Qin, and Haijing Diabetic Retinopathy Clinical Research Network. “A randomized trial comparing intravitreal triamcinolone and focal/grid photocoagulation for diabetic macular edema: baseline features.” Retina 28, no. 7 (2008): 919–30. https://doi.org/10.1097/IAE.0b013e31818144a7.
       Full Text  Link to Item
    • Boyer, David S., Andrew N. Antoszyk, Carl C. Awh, Robert B. Bhisitkul, Howard Shapiro, Nisha R. Acharya, and Nisha R. MARINA Study Group. “Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration.” Ophthalmology 114, no. 2 (February 2007): 246–52. https://doi.org/10.1016/j.ophtha.2006.10.045.
       Full Text  Link to Item
    • Diabetic Retinopathy Clinical Research Network, John A., Ronald P. Danis, Adam R. Glassman, Lloyd Paul Aiello, Andrew N. Antoszyk, Roy W. Beck, David J. Browning, et al. “Diurnal variation in retinal thickening measurement by optical coherence tomography in center-involved diabetic macular edema.” Arch Ophthalmol 124, no. 12 (December 2006): 1701–7. https://doi.org/10.1001/archopht.124.12.1701.
       Full Text  Link to Item
    • Diabetic Retinopathy Clinical Research Network, John A., Ronald P. Danis, Adam R. Glassman, Lloyd Paul Aiello, Andrew N. Antoszyk, Roy W. Beck, David J. Browning, et al. “Diurnal variation in retinal thickening measurement by optical coherence tomography in center-involved diabetic macular edema.” Arch Ophthalmol 124, no. 12 (December 2006): 1701–7. https://doi.org/10.1001/archopht.124.12.1701.
       Full Text  Link to Item
    • Complications of Age-Related Macular Degeneration Prevention Trial Research Group, C. M. “Laser treatment in patients with bilateral large drusen: the complications of age-related macular degeneration prevention trial.” Ophthalmology 113, no. 11 (November 2006): 1974–86. https://doi.org/10.1016/j.ophtha.2006.08.015.
       Full Text  Link to Item
    • Complications of Age-Related Macular Degeneration Prevention Trial Research Group, C. M. “Laser treatment in patients with bilateral large drusen: the complications of age-related macular degeneration prevention trial.” Ophthalmology 113, no. 11 (November 2006): 1974–86. https://doi.org/10.1016/j.ophtha.2006.08.015.
       Full Text  Link to Item
    • Heier, Jeffrey S., Andrew N. Antoszyk, Peter Reed Pavan, Steven R. Leff, Philip J. Rosenfeld, Thomas A. Ciulla, Richard F. Dreyer, et al. “Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study.” Ophthalmology 113, no. 4 (April 2006): 633.e1-633.e4. https://doi.org/10.1016/j.ophtha.2005.10.052.
       Full Text  Link to Item
    • Maguire, Maureen, and Maureen Complications of Age-Related Macular Degeneration Prevention Trial Research Group. “Baseline characteristics, the 25-Item National Eye Institute Visual Functioning Questionnaire, and their associations in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT).” Ophthalmology 111, no. 7 (July 2004): 1307–16. https://doi.org/10.1016/j.ophtha.2003.10.031.
       Full Text  Link to Item
    • Maguire, Maureen, and Maureen Complications of Age-Related Macular Degeneration Prevention Trial Research Group. “Baseline characteristics, the 25-Item National Eye Institute Visual Functioning Questionnaire, and their associations in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT).” Ophthalmology 111, no. 7 (July 2004): 1307–16. https://doi.org/10.1016/j.ophtha.2003.10.031.
       Full Text  Link to Item
    • Browning, David J., and Andrew N. Antoszyk. “Retinal tear and detachment after transpupillary thermotherapy for choroidal melanoma.” Am J Ophthalmol 135, no. 5 (May 2003): 729–30. https://doi.org/10.1016/s0002-9394(02)02111-6.
       Full Text  Link to Item
    • Browning, D. J., and A. N. Antoszyk. “The effect of the surgeon and the laser wavelength on the response to focal photocoagulation for diabetic macular edema.” Ophthalmology 106, no. 2 (February 1999): 243–48. https://doi.org/10.1016/S0161-6420(99)90063-5.
       Full Text  Link to Item
    • Browning, D. J., and A. N. Antoszyk. “Laser chorioretinal venous anastomosis for nonischemic central retinal vein occlusion.” Ophthalmology 105, no. 4 (April 1998): 670–77. https://doi.org/10.1016/S0161-6420(98)94022-2.
       Full Text  Link to Item
    • BLICE, J. P., T. J. ROBERTSON, A. N. ANTOSZYK, G. J. CHADER, and R. WALDBILLIG. “THE EFFECT OF INTRA-VITREAL LONG ARG IGF-I IN THE RABBIT EYE.” Investigative Ophthalmology & Visual Science 34, no. 4 (March 15, 1993): 1427–1427.
       Link to Item
    • ROBERTS, S. E., B. B. WARREN, and A. N. ANTOSZYK. “THE SAFETY OF INTRAVITREAL GENISTEIN IN RABBITS, A CLINICAL AND HISTOLOGIC-STUDY.” Investigative Ophthalmology & Visual Science 34, no. 4 (March 15, 1993): 1425–1425.
       Link to Item
    • Antoszyk, A. N., J. L. Gottlieb, R. Machemer, and D. L. Hatchell. “The effects of intravitreal triamcinolone acetonide on experimental pre-retinal neovascularization.” Graefes Arch Clin Exp Ophthalmol 231, no. 1 (1993): 34–40. https://doi.org/10.1007/BF01681698.
       Full Text  Link to Item
    • Byrnes, G. A., A. N. Antoszyk, D. O. Mazur, T. C. Kao, and S. A. Miller. “Photic maculopathy after extracapsular cataract surgery. A prospective study.” Ophthalmology 99, no. 5 (May 1992): 731–37. https://doi.org/10.1016/s0161-6420(92)31903-7.
       Full Text  Link to Item
    • ANTOSZYK, A. N., J. L. GOTTLIEB, P. SALOUPIS, R. CASEY, and D. L. HATCHELL. “SUPRESSION OF EXPERIMENTAL PRE-RETINAL NEOVASCULARIZATION WITH INTRAVITREAL TRIAMCINOLONE ACETONIDE.” Investigative Ophthalmology & Visual Science 32, no. 4 (March 15, 1991): 1046–1046.
       Link to Item
    • Antoszyk, A. N., J. L. Gottlieb, R. C. Casey, D. L. Hatchell, and R. Machemer. “An experimental model of preretinal neovascularization in the rabbit.” Invest Ophthalmol Vis Sci 32, no. 1 (January 1991): 46–52.
       Link to Item
    • Gottlieb, J. L., A. N. Antoszyk, D. L. Hatchell, and P. Saloupis. “The safety of intravitreal hyaluronidase. A clinical and histologic study.” Invest Ophthalmol Vis Sci 31, no. 11 (November 1990): 2345–52.
       Link to Item
    • Antoszyk, A. N., B. W. McCuen, E. de Juan, and R. Machemer. “Silicone oil injection after failed primary vitreous surgery in severe ocular trauma.” Am J Ophthalmol 107, no. 5 (May 15, 1989): 537–43. https://doi.org/10.1016/0002-9394(89)90501-1.
       Full Text  Link to Item
    • Antoszyk, A. N., E. de Juan, and M. B. Landers. “Subretinal hemorrhage during fluorescein angiography.” Am J Ophthalmol 103, no. 1 (January 15, 1987): 111–12. https://doi.org/10.1016/s0002-9394(14)74186-8.
       Full Text  Link to Item
    • Antoszyk, A., D. Robinson, A. D. Proia, and M. B. Shields. “Gelatin implants in glaucoma filtering surgery.” Am J Ophthalmol 101, no. 5 (May 15, 1986): 618–19. https://doi.org/10.1016/0002-9394(86)90962-1.
       Full Text  Link to Item
    • Antoszyk, A. N., and E. G. Buckley. “Contralateral decreased visual acuity and extraocular muscle palsies following retrobulbar anesthesia.” Ophthalmology 93, no. 4 (April 1986): 462–65. https://doi.org/10.1016/s0161-6420(86)33715-1.
       Full Text  Link to Item

  • Conference Papers

    • Scott, Ingrid U., Paul C. VanVeldhuisen, Michael S. Ip, Barbara A. Blodi, Neal L. Oden, Michael Altaweel, Daniel M. Berinstein, and Daniel M. SCORE2 Investigator Group. “Comparison of Monthly vs Treat-and-Extend Regimens for Individuals With Macular Edema Who Respond Well to Anti-Vascular Endothelial Growth Factor Medications: Secondary Outcomes From the SCORE2 Randomized Clinical Trial.” In Jama Ophthalmol, 136:337–45, 2018. https://doi.org/10.1001/jamaophthalmol.2017.6843.
       Full Text  Link to Item
    • Antoszyk, Andrew N., Carl W. Baker, Howard Cummings, Jorge Calzada, Joanna So, Carlos Quezada-Ruiz, and Zdenka Haskova. “Assessing the usability of the ranibizumab 0.5 mg prefilled syringe (PFS) by healthcare professionals in the US.” In Investigative Ophthalmology & Visual Science, Vol. 58. ASSOC RESEARCH VISION OPHTHALMOLOGY INC, 2017.
       Link to Item
    • Darafsheh, A., T. C. Hutchens, A. Fardad, A. N. Antoszyk, H. S. Ying, N. M. Fried, and V. N. Astratov. “Contact focusing multimodal probes for potential use in ophthalmic surgery with the Erbium:YAG laser.” In Progress in Biomedical Optics and Imaging  Proceedings of Spie, Vol. 8567, 2013. https://doi.org/10.1117/12.2005331.
       Full Text
    • Hutchens, T. C., A. Darafsheh, A. Fardad, A. N. Antoszyk, H. S. Ying, V. N. Astratov, and N. M. Fried. “Novel microsphere chain fiber tips for use in mid-infrared ophthalmic laser surgery.” In Progress in Biomedical Optics and Imaging  Proceedings of Spie, Vol. 8218, 2012. https://doi.org/10.1117/12.905614.
       Full Text
    • Darafsheh, A., A. Fardad, N. M. Fried, A. N. Antoszyk, H. S. Ying, and V. N. Astratov. “Ultra-precise focusing multimodal microprobes for contact laser tissue surgery.” In Optics Infobase Conference Papers, 2011.
    • Darafsheh, A., A. Fardad, N. M. Fried, A. N. Antoszyk, H. S. Ying, and V. N. Astratov. “Ultra-precise focusing multimodal microprobes for contact laser tissue surgery.” In 2011 Conference on Lasers and Electro Optics: Laser Science to Photonic Applications, Cleo 2011, 2011.
    • Darafsheh, A., K. W. Allen, A. Fardad, N. M. Fried, A. N. Antoszyk, H. S. Ying, and V. N. Astratov. “Focusing capability of integrated chains of microspheres in the limit of geometrical optics.” In Proceedings of Spie  the International Society for Optical Engineering, Vol. 7913, 2011. https://doi.org/10.1117/12.876139.
       Full Text
    • Darafsheh, A., M. D. Kerr, K. W. Allen, N. M. Fried, A. N. Antoszyk, H. S. Ying, and V. N. Astratov. “Integrated microsphere arrays: Light focusing and propagation effects.” In Proceedings of Spie  the International Society for Optical Engineering, Vol. 7605, 2010. https://doi.org/10.1117/12.845791.
       Full Text
    • Cordell, W. H., R. K. Maturi, T. M. Costigan, M. F. Marmor, R. G. Weleber, S. G. Coupland, R. P. Danis, et al. “Tadalafil 5 mg or sildenafil citrate 50 mg administered daily for up to 6 months does not affect visual safety.” In Journal of Sexual Medicine, 5:77–77. BLACKWELL PUBLISHING, 2008.
       Link to Item
    • Cordell, William H., Raj K. Maturi, Timoth M. Costigan, Michael F. Marmor, Richard G. Weleber, Stuart G. Coupland, Ronald P. Danis, et al. “Tadalafil 5 mg or sildenafil citrate 50 mg administered daily for up to 6 months does not affect visual safety.” In Journal of Sexual Medicine, 5:27–27. BLACKWELL PUBLISHING, 2008.
       Link to Item
    • Diabetic Retinopathy Clinical Research Network, Päivi H., David J. Browning, Adam R. Glassman, Lloyd Paul Aiello, Roy W. Beck, David M. Brown, Donald S. Fong, et al. “Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema.” In Ophthalmology, 114:525–36, 2007. https://doi.org/10.1016/j.ophtha.2006.06.052.
       Full Text  Link to Item
    • Diabetic Retinopathy Clinical Research Network, Päivi H., David J. Browning, Adam R. Glassman, Lloyd Paul Aiello, Roy W. Beck, David M. Brown, Donald S. Fong, et al. “Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema.” In Ophthalmology, 114:525–36, 2007. https://doi.org/10.1016/j.ophtha.2006.06.052.
       Full Text  Link to Item
    • Heier, J. S., P. J. Rosenfeld, A. N. Antoszyk, G. Hantsbarger, R. Kim, and N. Shams. “Long-term experience with lucentis (ranibizumab) in patients with neovascular age-related macular degeneration (AMD).” In Investigative Ophthalmology & Visual Science, Vol. 46. ASSOC RESEARCH VISION OPHTHALMOLOGY INC, 2005.
       Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.